AMPA receptor inhibitors for the treatment of epilepsy: the role of perampanel. (Q38112213)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23739002%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

title

AMPA receptor inhibitors for the treatment of epilepsy: the role of perampanel (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23739002%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23739002%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Alfonso Iudice

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23739002%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

author name string

Gaetano Zaccara

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23739002%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Fabio Giovannelli

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23739002%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

language of work or name

1 reference

1 June 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23739002%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

2 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23739002%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23739002%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23739002%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

page(s)

647-655

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23739002%20AND%20SRC:MED&resulttype=core&format=json

Emerging drugs for epilepsy

2 March 2020

cites work

1 reference

Antiepileptic drug therapy the story so far.

21 January 2018

1 reference

GABAergic drugs in the treatment of epilepsy: modern or outmoded?

21 January 2018

1 reference

Molecular targets for antiepileptic drug development

21 January 2018

1 reference

21 January 2018

1 reference

Synaptic AMPA receptor plasticity and behavior.

21 January 2018

1 reference

Kainate receptors: pharmacology, function and therapeutic potential

21 January 2018

1 reference

Stargazin modulates AMPA receptor antagonism

21 January 2018

1 reference

Revisiting AMPA receptors as an antiepileptic drug target

21 January 2018

1 reference

The NMDA receptor complex as a therapeutic target in epilepsy: a review

21 January 2018

1 reference

AMPA receptor antagonists as potential anticonvulsant drugs

21 January 2018

1 reference

NMDA receptors in clinical neurology: excitatory times ahead

21 January 2018

1 reference

Perampanel: a novel, orally active, noncompetitive AMPA-receptor antagonist that reduces seizure activity in rodent models of epilepsy

21 January 2018

1 reference

Talampanel, a new antiepileptic drug: single- and multiple-dose pharmacokinetics and initial 1-week experience in patients with chronic intractable epilepsy

21 January 2018

1 reference

21 January 2018

1 reference

Diurnal fluctuations in free and total steady-state plasma levels of carbamazepine and correlation with intermittent side effects

21 January 2018

1 reference

Exposure-response analysis reveals that clinically important toxicity difference can exist between bioequivalent carbamazepine tablets

21 January 2018

1 reference

Non-dopaminergic treatments in development for Parkinson's disease

21 January 2018

1 reference

Safety and efficacy of perampanel in advanced Parkinson's disease: a randomized, placebo-controlled study

21 January 2018

1 reference

AMPA receptor blockade improves levodopa-induced dyskinesia in MPTP monkeys

21 January 2018

1 reference

LY293558, an AMPA glutamate receptor antagonist, prevents and reverses levodopa-induced motor alterations in Parkinsonian rats

21 January 2018

1 reference

Tolerability and safety of perampanel: two randomized dose-escalation studies.

21 January 2018

1 reference

Adjunctive perampanel for refractory partial-onset seizures: randomized phase III study 304

21 January 2018

1 reference

Randomized phase III study 306: adjunctive perampanel for refractory partial-onset seizures.

21 January 2018

1 reference

Perampanel, a selective, noncompetitive α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist, as adjunctive therapy for refractory partial-onset seizures: interim results from phase III, extension study 307.

21 January 2018

1 reference

Idiosyncratic adverse reactions to antiepileptic drugs

21 January 2018

1 reference

Cognitive enhancing effects of an AMPA receptor positive modulator on place learning in mice.

21 January 2018

1 reference

Topiramate dose effects on cognition: a randomized double-blind study

21 January 2018

1 reference

Weight issues for people with epilepsy--a review

21 January 2018

1 reference

Perampanel, a novel, non-competitive, selective AMPA receptor antagonist as adjunctive therapy for treatment-resistant partial-onset seizures

21 January 2018

1 reference

Retigabine for partial onset seizures.

21 January 2018

1 reference

Pharmacotherapy of the third-generation AEDs: lacosamide, retigabine and eslicarbazepine acetate

21 January 2018

1 reference